NeuroAiD™II has been awarded Gold accreditation by
independent nonprofit Empowered By Evidence (EBE)
Bringing Innovative Solutions to Healthcare Practitioners
Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries Of The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Shaping the Future of Neurological Care
David Picard, CEO of Moleac, shares insights on unmet needs in post-stroke care and the role of science in improving outcomes for neurological conditions.
Latest News
Could Blood Lead Screening Play a Role in Stroke Prevention? New Insights from a US National Health Survey
📰🧠🔬 STROKE STUDY HIGHLIGHTS – Association between blood lead levels and stroke: Evidence from a US National Health Survey by Li J., et al.
Moleac at the 6ᵗʰ World AVM Congress & SNVIS ASM 2026 in Singapore
Protecting Island Ecosystems: Moleac’s Support for Seacology in Pitas Laut
At Moleac, we are incredibly proud to support Seacology and their ambition to protect marine life worldwide.
Moleac is pleased to announce that NeuroAiD™II has been awarded Gold accreditation by Empowered By Evidence.
Advancing Post-Stroke Care: Moleac at the J.P. Morgan Healthcare Conference
We’re pleased to share that David Picard, CEO of Moleac, was recently interviewed at the J.P. Morgan Healthcare Conference in San Francisco.
When Does Physical Activity Matter Most for Dementia Risk? Insights from the Framingham Heart Study
Understanding Bladder and Bowel Control After Spinal Cord Injury
How does a spinal cord injury affect bladder and bowel control?
Dementia Study Highlights: How White Matter Hyperintensity Topography Impacts Cognitive Domains
Supporting Behavioural Recovery After Traumatic Brain Injury: Insights for Caregivers from Dr. Mea Sung
Protecting Endangered Turtles in Pitas Laut: A Community Story of Hope
🐢 A Story of Hope from Pitas Laut, Malaysia 🌴 Some projects simply touch our hearts and remind us of the power of working together for a better world.
